• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔环境在HIV-1传播中的作用。

The role of the oral environment in HIV-1 transmission.

作者信息

Shugars D C, Wahl S M

机构信息

Department of Dental Ecology, School of Dentistry, University of North Carolina at Chapel Hill 27599-7450, USA.

出版信息

J Am Dent Assoc. 1998 Jul;129(7):851-8. doi: 10.14219/jada.archive.1998.0349.

DOI:10.14219/jada.archive.1998.0349
PMID:9685760
Abstract

Human immunodeficiency virus type 1, or HIV-1, is infrequently transmitted through the mouth, unlike other mucosal sites. Factors such as low salivary viral titers, low numbers of CD4-positive target cells, anti-HIV antibodies and endogenous salivary antiviral factors work in concert to protect oral tissues from infection and reduce the risk of viral transmission through salivary secretions. This review summarizes the various factors thought to influence oral transmission HIV-1, focusing on the mucosal protein secretory leukocyte protease inhibitor, or SLPI.

摘要

与其他黏膜部位不同,1型人类免疫缺陷病毒(HIV-1)很少通过口腔传播。唾液病毒滴度低、CD4阳性靶细胞数量少、抗HIV抗体以及内源性唾液抗病毒因子等因素共同作用,保护口腔组织免受感染,并降低通过唾液分泌物传播病毒的风险。本综述总结了被认为影响HIV-1口腔传播的各种因素,重点关注黏膜蛋白分泌型白细胞蛋白酶抑制剂(SLPI)。

相似文献

1
The role of the oral environment in HIV-1 transmission.口腔环境在HIV-1传播中的作用。
J Am Dent Assoc. 1998 Jul;129(7):851-8. doi: 10.14219/jada.archive.1998.0349.
2
Endogenous mucosal antiviral factors of the oral cavity.口腔内源性黏膜抗病毒因子。
J Infect Dis. 1999 May;179 Suppl 3:S431-5. doi: 10.1086/314799.
3
Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.人唾液中分泌型白细胞蛋白酶抑制剂(SLPI)的抑制功能具有HIV-1特异性,并随病毒嗜性而变化。
Oral Dis. 2002 May;8(3):160-7. doi: 10.1034/j.1601-0825.2002.01807.x.
4
Oral transmission of HIV, reality or fiction? An update.HIV的口腔传播:事实还是虚构?最新情况
Oral Dis. 2006 May;12(3):219-28. doi: 10.1111/j.1601-0825.2005.01187.x.
5
Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.黏膜组织中HIV-1与其内源性抑制剂之间的解剖学分离。
Am J Pathol. 1997 Apr;150(4):1275-84.
6
Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.粘膜液中的分泌型白细胞蛋白酶抑制剂(SLPI)可抑制HIV-1。
Oral Dis. 1997 May;3 Suppl 1:S64-9. doi: 10.1111/j.1601-0825.1997.tb00377.x.
7
Endogenous salivary inhibitors of human immunodeficiency virus.人类免疫缺陷病毒的内源性唾液抑制剂
Arch Oral Biol. 1999 Jun;44(6):445-53. doi: 10.1016/s0003-9969(99)00003-5.
8
Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.分泌型白细胞蛋白酶抑制剂可阻断人免疫缺陷病毒I型嗜单核细胞和嗜淋巴细胞毒株对原代单核细胞和单核细胞的感染性。
Oral Dis. 1997 May;3 Suppl 1:S70-2. doi: 10.1111/j.1601-0825.1997.tb00379.x.
9
Differential mucosal susceptibility in HIV-1 transmission and infection.HIV-1传播与感染中黏膜易感性的差异
Adv Dent Res. 2006 Apr 1;19(1):52-6. doi: 10.1177/154407370601900111.
10
Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.抗逆转录病毒治疗长期使用的 HIV 感染者口腔分泌型白细胞蛋白酶抑制剂的表达。
J Oral Pathol Med. 2013 Mar;42(3):208-15. doi: 10.1111/jop.12023. Epub 2012 Nov 6.

引用本文的文献

1
Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes.唾液免疫球蛋白 A 和淀粉酶水平与 2 型糖尿病患者口腔牙科表现的相关性:控制组与非控制组患者的比较。
BMC Oral Health. 2019 Aug 6;19(1):175. doi: 10.1186/s12903-019-0868-4.
2
Expert consensus statement on the science of HIV in the context of criminal law.关于刑法中 HIV 科学的专家共识声明。
J Int AIDS Soc. 2018 Jul;21(7):e25161. doi: 10.1002/jia2.25161.
3
Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
黏液和黏蛋白:它们在抑制人类免疫缺陷病毒中发挥作用吗?
Virol J. 2017 Oct 6;14(1):192. doi: 10.1186/s12985-017-0855-9.
4
The Role of Defensins in HIV Pathogenesis.防御素在 HIV 发病机制中的作用。
Mediators Inflamm. 2017;2017:5186904. doi: 10.1155/2017/5186904. Epub 2017 Aug 3.
5
Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.唾液分泌型白细胞蛋白酶抑制剂(SLPI)与头颈癌:癌症预防研究II营养队列研究
Oral Oncol. 2016 Apr;55:1-5. doi: 10.1016/j.oraloncology.2016.02.004. Epub 2016 Feb 24.
6
SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion.分泌性白细胞蛋白酶抑制因子基因敲低诱导胰腺导管腺癌细胞增殖和侵袭。
Cancer Cell Int. 2015 Apr 1;15:37. doi: 10.1186/s12935-015-0182-4. eCollection 2015.
7
Molecular mechanisms of taste recognition: considerations about the role of saliva.味觉识别的分子机制:关于唾液作用的思考
Int J Mol Sci. 2015 Mar 13;16(3):5945-74. doi: 10.3390/ijms16035945.
8
HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.参与艾滋病临床试验组A5077研究的HIV-1感染男性和女性血液及非血液区室中的HIV-1 RNA水平和抗逆转录病毒药物耐药性
PLoS One. 2014 Apr 3;9(4):e93537. doi: 10.1371/journal.pone.0093537. eCollection 2014.
9
Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.人类免疫缺陷病毒患者与健康个体唾液分泌型白细胞蛋白酶抑制剂的评估与比较。
Indian J Palliat Care. 2014 Jan;20(1):26-30. doi: 10.4103/0973-1075.125551.
10
Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals.定量分析人类免疫缺陷病毒 1 型(HIV-1)感染者唾液中差异表达的蛋白质。
Anal Chim Acta. 2013 Apr 24;774:61-6. doi: 10.1016/j.aca.2013.02.038. Epub 2013 Mar 1.